| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8743940 | Travel Medicine and Infectious Disease | 2017 | 10 Pages |
Abstract
Overall, the number of deaths that we could reliably attribute to the prophylactic use of mefloquine is very low.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Maya Tickell-Painter, Rachel Saunders, Nicola Maayan, Vittoria Lutje, Alberto Mateo-Urdiales, Paul Garner,